Sanofi-Aventis Fails To Kill FCA Suit Over Lovenox
By Michael Lipkin
Law360, Los Angeles (May 13, 2014, 5:48 PM ET) -- A California federal judge on Tuesday declined to give Sanofi-Aventis SA an early escape from rival Amphastar Pharmaceutical Inc.’s False Claims Act suit alleging the company fraudulently inflated the price of its anticoagulant drug Lovenox, ruling Amphastar had properly disclosed information to the government before filing.
U.S. District Judge Marvin J. Garbis denied Sanofi-Aventis’ motion for summary judgment for lack of jurisdiction. The company had argued that Amphastar’s prefiling disclosure letter to the government was only a summary of allegations it intended to make and did not reveal...